Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Current Diabetes Reports|April 27, 2016
Islet AutoantibodiesVito Lampasona, Daniela Liberati
Cancer Biomarkers : Section a of Disease Markers|April 18, 2018
No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassayDaniela Liberati, Ilaria Marzinotto, Cristina Brigatti, et al.
Diabetes|March 9, 2016
Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 DiabetesKerry A McLaughlin, Carolyn C Richardson, Aarthi Ravishankar, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 9, 2018
Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcomeErica Dugnani, Valeria Sordi, Silvia Pellegrini, et al.
Scientific Reports|October 27, 2017
miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFAIlaria Marzinotto, Silvia Pellegrini, Cristina Brigatti, et al.
Journal of Autoimmunity|November 20, 2003
Fine mapping of diabetes-associated IA-2 specific autoantibodiesMassimo Bearzatto, Vito Lampasona, Cristina Belloni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II TrialMichele Reni, Erica Dugnani, Stefano Cereda, et al.
Diabetes Care|September 20, 2011
Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2βMichael Schlosser, Patricia W Mueller, Peter Achenbach, et al.
Journal of Immunological Methods|May 27, 2008
Radiobinding assay for detecting autoantibodies to single epitopesVito Lampasona, Cristina Belloni, Sandra Piquer, et al.
Pageof 10